Grégory Behar

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Grégory Behar

Earlier roles on record: Board Member at Seres Therapeutics, Inc. (MCRB) until October 2, 2023. Seres Therapeutics, Inc. reported in an 8-K filed October 4, 2023 that Grégory Behar resigned as board of directors, effective October 2, 2023.

“On October 2, 2023, Grégory Behar informed Seres Therapeutics, Inc. (the "Company") of his resignation from the board of directors of the Company, effective immediately, in connection with his resignation from Nestlé Health Science.”

Seres Therapeutics, Inc. Form 8-K, filed October 4, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Research with Equibles

Turn this profile into a cited research brief

Start with a question tailored to the filings and events on this page, or connect Equibles financial data to ChatGPT or Claude.

Suggested question: “Summarize Grégory Behar's recent executive appointments or departures and cite the source filings.”

Use in your AI

Affiliation history

Recorded current and former roles; source labels appear when available.

Seres Therapeutics, Inc. (MCRB)
Board Member

Proxy statement

2014-01-01–2023-10-02

Company network

Recorded roles and call appearances connecting this person to public companies.

Seres Therapeutics, Inc.

MCRB

Board Member

2014-01-01–2023-10-02

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Executive change Resigned: board of directors Seres Therapeutics, Inc. (MCRB)
2023-10-02